Unknown

Dataset Information

0

An Engineered Human Fc variant With Exquisite Selectivity for Fc?RIIIaV158 Reveals That Ligation of Fc?RIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages.


ABSTRACT: IgG antibodies mediate the clearance of target cells via the engagement of Fc gamma receptors (Fc?Rs) on effector cells by eliciting antibody-dependent cellular cytotoxicity and phagocytosis (ADCC and ADCP, respectively). Because (i) the IgG Fc domain binds to multiple Fc?Rs with varying affinities; (ii) even low Fc:Fc?Rs affinity interactions can play a significant role when antibodies are engaged in high avidity immune complexes and (iii) most effector cells express multiple Fc?Rs, the clearance mechanisms that can be mediated by individual Fc?R are not well-understood. Human Fc?RIIIa (hFc?RIIIa; CD16a), which exists as two polymorphic variants at position 158, hFc?RIIIaV158 and hFc?RIIIaF158, is widely considered to only trigger ADCC, especially with natural killer (NK) cells as effectors. To evaluate the role of hFc?RIIIa ligation in myeloid-derived effector cells, and in particular on macrophages and monocytes which express multiple Fc?Rs, we engineered an aglycosylated engineered human Fc (hFc) variant, Fc3aV, which binds exclusively to hFc?RIIIaV158. Antibodies formatted with the Fc3aV variant bind to the hFc?RIIIaV158 allotype with a somewhat lower KD than their wild type IgG1 counterparts, but not to any other hFc?R. The exceptional selectivity for hFc?RIIIaV158 was demonstrated by SPR using increased avidity, dimerized GST-fused versions of the ectodomains of hFc?Rs and from the absence of binding of large immune complex (IC) to CHO cells expressing each of the hFc?Rs, including notably, the Fc?RIIIaF158 variant or the highly homologous Fc?RIIIb. We show that even though monocyte-derived GM-CSF differentiated macrophages express hFc?RIIIa at substantially lower levels than the other two major activating receptors, namely hFc?RI or hFc?RIIa, Fc3aV-formatted Rituximab and Herceptin perform ADCP toward CD20- and Her2-expressing cancer cells, respectively, at a level comparable to that of the respective wild-type antibodies. We further show that hFc?RIIIa activation plays a significant role on ADCC by human peripheral monocytes. Our data highlight the utility of Fc3aV and other similarly engineered exquisitely selective, aglycosylated Fc variants toward other hFc?Rs as tools for the detailed molecular understanding of hFc?R biology.

SUBMITTER: Kang TH 

PROVIDER: S-EPMC6448688 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa<sub>V158</sub> Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages.

Kang Tae Hyun TH   Lee Chang-Han CH   Delidakis George G   Jung Jiwon J   Richard-Le Goff Odile O   Lee Jiwon J   Kim Jin Eyun JE   Charab Wissam W   Bruhns Pierre P   Georgiou George G  

Frontiers in immunology 20190327


IgG antibodies mediate the clearance of target cells via the engagement of Fc gamma receptors (FcγRs) on effector cells by eliciting antibody-dependent cellular cytotoxicity and phagocytosis (ADCC and ADCP, respectively). Because (i) the IgG Fc domain binds to multiple FcγRs with varying affinities; (ii) even low Fc:FcγRs affinity interactions can play a significant role when antibodies are engaged in high avidity immune complexes and (iii) most effector cells express multiple FcγRs, the clearan  ...[more]

Similar Datasets

| S-EPMC7294930 | biostudies-literature
| S-EPMC6166597 | biostudies-literature
| S-EPMC10560851 | biostudies-literature
| S-EPMC3679097 | biostudies-literature
| S-EPMC6102347 | biostudies-literature
| S-EPMC4769027 | biostudies-literature
| S-EPMC7037240 | biostudies-literature
| S-EPMC5126582 | biostudies-literature
| S-EPMC4134187 | biostudies-literature
| S-EPMC9850113 | biostudies-literature